Description

Letrozol Coated Tablets 2.5 mg. №100

Ingredients

Each coated tablet contains 2.5 mg of Letrozole as the active ingredient.

Mechanism of Action

Letrozole, the active ingredient in Letrozol tablets, is an aromatase inhibitor that works by reducing the production of estrogen in the body.

Pharmacological Properties

Letrozole inhibits the aromatase enzyme, thereby decreasing estrogen levels, which is crucial in the treatment of hormone receptor-positive breast cancer.

Indications for Use

Letrozol is indicated for the treatment of hormone receptor-positive breast cancer in postmenopausal women.

Contraindications

Do not use Letrozol if you are pregnant, as it may cause harm to the unborn baby.

Side Effects

Common side effects of Letrozol may include hot flashes, fatigue, and joint pain. Contact your healthcare provider if you experience severe side effects.

Usage Instructions

The recommended dosage of Letrozol is 2.5 mg once daily, with or without food. Take Letrozol exactly as prescribed by your healthcare provider.

Benefits Compared to Analogues

Clinical trials have demonstrated the efficacy of Letrozole in improving disease-free survival and reducing the risk of cancer recurrence compared to other treatment options.

Suitable Patient Groups

Letrozol is suitable for postmenopausal women with hormone receptor-positive breast cancer.

Storage and Shelf Life

Store Letrozol coated tablets at room temperature away from moisture and heat. Check the expiration date on the packaging before use.

Packaging Description

Letrozol is available in packages containing 100 coated tablets of 2.5 mg each.

Clinical Evidence and Proven Effectiveness

Research published in the New England Journal of Medicine has highlighted the benefits of Letrozole in the adjuvant treatment of early-stage breast cancer. The study showed a significant improvement in disease-free survival rates in postmenopausal women with hormone receptor-positive breast cancer who received Letrozole compared to tamoxifen.